167 related articles for article (PubMed ID: 9544219)
1. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
2. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
[TBL] [Abstract][Full Text] [Related]
4. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.
Berglund BA; Fleming PR; Rice KC; Shim JY; Welsh WJ; Howlett AC
Drug Des Discov; 2000; 16(4):281-94. PubMed ID: 10807034
[TBL] [Abstract][Full Text] [Related]
7. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
[TBL] [Abstract][Full Text] [Related]
8. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
[TBL] [Abstract][Full Text] [Related]
9. Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
Krishnamurthy M; Gurley S; Moore BM
Bioorg Med Chem; 2008 Jul; 16(13):6489-500. PubMed ID: 18524604
[TBL] [Abstract][Full Text] [Related]
10. Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues.
Drake DJ; Jensen RS; Busch-Petersen J; Kawakami JK; Concepcion Fernandez-Garcia M; Fan P; Makriyannis A; Tius MA
J Med Chem; 1998 Sep; 41(19):3596-608. PubMed ID: 9733485
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
[TBL] [Abstract][Full Text] [Related]
12. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.
Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T
Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Joshi SN; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Jan; 14(1):247-62. PubMed ID: 16165365
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
Melvin LS; Milne GM; Johnson MR; Subramaniam B; Wilken GH; Howlett AC
Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
[TBL] [Abstract][Full Text] [Related]
15. Potent cyano and carboxamido side-chain analogues of 1', 1'-dimethyl-delta8-tetrahydrocannabinol.
Singer M; Ryan WJ; Saha B; Martin BR; Razdan RK
J Med Chem; 1998 Oct; 41(22):4400-7. PubMed ID: 9784115
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.
Martin BR; Jefferson R; Winckler R; Wiley JL; Huffman JW; Crocker PJ; Saha B; Razdan RK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1065-79. PubMed ID: 10454479
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of substitutions at the C-1 position of Delta9-tetrahydrocannabinol.
Burdick D; DeOrazio R; Guzzo P; Habershaw A; Helle M; Paul B; Wolf M
Bioorg Med Chem Lett; 2010 Feb; 20(4):1424-6. PubMed ID: 20079638
[TBL] [Abstract][Full Text] [Related]
18. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
Rhee MH; Vogel Z; Barg J; Bayewitch M; Levy R; Hanus L; Breuer A; Mechoulam R
J Med Chem; 1997 Sep; 40(20):3228-33. PubMed ID: 9379442
[TBL] [Abstract][Full Text] [Related]
19. Structure elucidation and conformational properties of synthetic cannabinoids (-)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibe nzo [b,d]pyranyl)-2-hexyl-1,3-dithiolane and its methylated analog.
Mavromoustakos T; Theodoropoulou E; Zervou M; Kourouli T; Papahatjis D
J Pharm Biomed Anal; 1999 Jan; 18(6):947-56. PubMed ID: 9925329
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
Govaerts SJ; Hermans E; Lambert DM
Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
